Literature Collection

Magnifying Glass
Collection Insights

11K+

References

9K+

Articles

1400+

Grey Literature

4600+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Year
Sort by
Order
Show
11202 Results
10941
Validation of a Brief PTSD Screener for Underserved Patients in Federally Qualified Health Centers
Type: Journal Article
Authors: Bing Han, Eunice C. Wong, Zhimin Mao, Lisa S. Meredith, Andrea Cassells, Jonathan N. Tobin
Year: 2015
Topic(s):
General Literature See topic collection
10942
Validation of a contemplation ladder in an adult substance use disorder sample
Type: Journal Article
Authors: A. D. Hogue
Year: 2010
Topic(s):
Opioids & Substance Use See topic collection
,
Measures See topic collection
10943
Validation of a new risk assessment tool: the Brief Risk Questionnaire
Type: Journal Article
Authors: T. Jones, S. Lookatch, T. Moore
Year: 2015
Publication Place: United States
Abstract: Opioids remain a common method of treating chronic pain conditions despite some controversy. In an effort to address some of the risks of opioid medications, opioid risk assessment has become a standard of care when opioids are used to treat a chronic pain condition. Research to date has found that many currently available patient-completed written questionnaires are relatively poor at identifying which patients will engage in medication aberrant behavior in the future. Clinical interview techniques have been found to provide better prediction, but practitioners often prefer the convenience of patient-completed tools. In this study, a new brief patient-completed risk tool, the Brief Risk Questionnaire (BRQ), was created and compared with a structured clinical interview and two commonly used patient-completed risk assessment tools: the Opioid Risk Tool (ORT) and Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R). The different risk assessment measures were administered to 454 patients at a pain clinic and their prediction of medication aberrant behavior at 6-month follow-up was compared. Results found that the BRQ was able to predict future medication aberrant behavior better than the other two patient-completed risk measures and almost as well overall as a structured clinical interview rating system. This study indicates that the BRQ could be a useful new tool for clinicians in conducting opioid risk assessment.
Topic(s):
Opioids & Substance Use See topic collection
,
Measures See topic collection
10944
Validation of a screening risk index for serious prescription opioid-induced respiratory depression or overdose in a US commercial health plan claims database
Type: Journal Article
Authors: Barbara K. Zedler, William B. Saunders, Andrew R. Joyce, Catherine C. Vick, E. L. Murrelle
Year: 2018
Topic(s):
Measures See topic collection
,
Opioids & Substance Use See topic collection
10946
Validation of an Expanded Measure of Integrated Care Provider Fidelity: PPAQ-2
Type: Journal Article
Authors: G. P. Beehler, J. S. Funderburk, P. R. King, K. Possemato, J. A. Maddoux, W. R. Goldstein, M. Wade
Year: 2019
Publication Place: United States
Abstract: This study aimed to validate the factor structure of the expanded Primary Care Behavioral Health Provider Adherence Questionnaire (PPAQ-2), which is designed to assess provider fidelity to both the Primary Care Behavioral Health (PCBH) and collaborative care management (CCM) models of integrated primary care. Two-hundred fifty-three integrated care providers completed self-reports of professional background, perceptions of clinic integration and related practice barriers, and the PPAQ-2. Confirmatory factor analyses were conducted to assess the theorized factor structure and criterion validity was assessed through correlational analysis. Factor analyses demonstrated adequate fit with the data and acceptable to excellent composite reliabilities across five PCBH domains and five CCM domains. Validity was demonstrated by correlations between adherence scores and measures of clinic integration and barriers to fidelity. The PPAQ-2 is a psychometrically sound measure that can be used in future integrated care dismantling studies to identify provider behaviors that best predict patient outcomes.
Topic(s):
Measures See topic collection
10947
Validation of an Expanded Measure of Integrated Care Provider Fidelity: PPAQ-2
Type: Journal Article
Authors: G. P. Beehler, J. S. Funderburk, P. R. King, K. Possemato, J. A. Maddoux, W. R. Goldstein, M. Wade
Year: 2020
Publication Place: United States
Abstract: This study aimed to validate the factor structure of the expanded Primary Care Behavioral Health Provider Adherence Questionnaire (PPAQ-2), which is designed to assess provider fidelity to both the Primary Care Behavioral Health (PCBH) and collaborative care management (CCM) models of integrated primary care. Two-hundred fifty-three integrated care providers completed self-reports of professional background, perceptions of clinic integration and related practice barriers, and the PPAQ-2. Confirmatory factor analyses were conducted to assess the theorized factor structure and criterion validity was assessed through correlational analysis. Factor analyses demonstrated adequate fit with the data and acceptable to excellent composite reliabilities across five PCBH domains and five CCM domains. Validity was demonstrated by correlations between adherence scores and measures of clinic integration and barriers to fidelity. The PPAQ-2 is a psychometrically sound measure that can be used in future integrated care dismantling studies to identify provider behaviors that best predict patient outcomes.
Topic(s):
General Literature See topic collection
10948
Validation of an Expanded Measure of Integrated Care Provider Fidelity: PPAQ-2
Type: Journal Article
Authors: G. P. Beehler, J. S. Funderburk, P. R. King, K. Possemato, J. A. Maddoux, W. R. Goldstein, M. Wade
Year: 2020
Publication Place: United States
Abstract: This study aimed to validate the factor structure of the expanded Primary Care Behavioral Health Provider Adherence Questionnaire (PPAQ-2), which is designed to assess provider fidelity to both the Primary Care Behavioral Health (PCBH) and collaborative care management (CCM) models of integrated primary care. Two-hundred fifty-three integrated care providers completed self-reports of professional background, perceptions of clinic integration and related practice barriers, and the PPAQ-2. Confirmatory factor analyses were conducted to assess the theorized factor structure and criterion validity was assessed through correlational analysis. Factor analyses demonstrated adequate fit with the data and acceptable to excellent composite reliabilities across five PCBH domains and five CCM domains. Validity was demonstrated by correlations between adherence scores and measures of clinic integration and barriers to fidelity. The PPAQ-2 is a psychometrically sound measure that can be used in future integrated care dismantling studies to identify provider behaviors that best predict patient outcomes.
Topic(s):
General Literature See topic collection
10949
Validation of the "problematic use of narcotics" (PUN) screening test for drug using adolescents
Type: Journal Article
Authors: K. Okulicz-Kozaryn, J. Sieroslawski
Year: 2007
Publication Place: England
Abstract: The aim of the study was to examine psychometric properties of the PUN screening test concerning illicit drug problem use by adolescents. The criterion standard for the test's validity was a diagnostic interview conducted by trained specialists. Respondents were reached by snowball sampling in 58 randomly chosen Polish local communities. A total of 1344 adolescent (37% female) aged 13 to 18 years, who used any illicit drug at least once in the past 12 months, participated. The majority (89%) had no contacts with any drug therapy facilities. 41% were diagnosed as occasional drug users and 59% as problematic users or dependents. Logistic regression analysis showed that 10 out of the basic set of 25 test items were most powerful in differentiating occasional and problematic users. A test score of 2 or higher was optimal for identifying problem drug use (sensitivity: 0.88, specificity: 0.79, PPV: 0.86, NPV: 0.81). Validity was not affected by age or sex. These results confirmed the PUN test potential as a brief screening tool.
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
,
Measures See topic collection
10950
Validation of the diagnosis of autism in general practitioner records
Type: Journal Article
Authors: E. Fombonne, L. Heavey, L. Smeeth, L. C. Rodrigues, C. Cook, P. G. Smith, L. Meng, A. J. Hall
Year: 2004
Publication Place: England
Abstract: BACKGROUND: We report on the validity of the computerized diagnoses of autism in a large case-control study investigating the possible association between autism and the measles, mumps and rubella vaccine in the UK using the General Practitioner Research Database (GPRD). We examined anonymized copies of all relevant available clinical reports, including general practitioners' (GP) notes, consultant, speech therapy and educational psychologists reports, on 318 subjects born between 1973 and 1997 with a diagnosis of autism or a related disorder recorded in their electronic general practice record. METHODS: Data were abstracted to a case validation form allowing for the identification of developmental symptoms relevant to the diagnosis of pervasive developmental disorders (PDDs). Information on other background clinical and familial features was also abstracted. A subset of 50 notes was coded independently by 2 raters to derive reliability estimates for key clinical characteristics. RESULTS: For 294 subjects (92.5%) the diagnosis of PDD was confirmed after review of the records. Of these, 180 subjects (61.2%) fulfilled criteria for autistic disorder. The mean age at first recording of a PDD diagnosis in the GPRD database was 6.3 years (SD = 4.6). Consistent with previous estimates, the proportion of subjects experiencing regression in the course of their development was 19%. Inter-rater reliability for the presence of a PDD diagnosis was good (kappa =.73), and agreement on clinical features such as regression, age of parental recognition of first symptoms, language delay and presence of epilepsy was also good (kappas ranging from.56 to 1.0). CONCLUSIONS: This study provides evidence that the positive predictive value of a diagnosis of autism recorded in the GPRD is high.
Topic(s):
HIT & Telehealth See topic collection
10951
Validation of the revised Problems Assessment for Substance Using Psychiatric Patients
Type: Journal Article
Authors: Paula C. Vincent, Clara M. Bradizza, Kate B. Carey, Stephen A. Maisto, Paul R. Stasiewicz, Gerard J. Connors, Nicole D. Mercer
Year: 2011
Topic(s):
Opioids & Substance Use See topic collection
,
Measures See topic collection
10952
Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R)
Type: Journal Article
Authors: S. F. Butler, K. Fernandez, C. Benoit, S. H. Budman, R. N. Jamison
Year: 2008
Publication Place: United States
Abstract: UNLABELLED: The original Screener and Opioid Assessment for Patients with Pain (SOAPP) is a conceptually derived self-report questionnaire designed to predict aberrant medication-related behaviors among chronic pain patients considered for long-term opioid therapy. The purpose of this study was to develop and validate an empirically derived version of the SOAPP (SOAPP-R) that addresses some limitations of the original SOAPP. In successive steps, items were reduced from an initial pool of 142 to a 97-item beta version. The beta version was administered to 283 chronic pain patients receiving long-term opioid therapy. Items were evaluated based on data collected at follow-up, including correlation with the Aberrant Drug Behavior Index (ADBI), derived from interview data, physician ratings, and urine toxicology screens. Twenty-four items were retained and comprise the final SOAPP-R. Coefficient alpha was .88, and receiver operating characteristics curve analysis yielded an area under the curve of .81 (P < .001). A cutoff score of 18 showed adequate sensitivity (.81) and specificity (.68). The obtained psychometrics, along with the use of a predictive criterion that goes beyond self-report, suggest that the SOAPP-R is an improvement over the original version in screening risk potential for aberrant medication-related behavior among persons with chronic pain. PERSPECTIVE: There is a need for a screener for abuse risk in patients prescribed opioids for pain. This study presents a revised version of the SOAPP-R that is empirically derived with good reliability and validity but is less susceptible to overt deception than the original SOAPP version 1.
Topic(s):
Opioids & Substance Use See topic collection
,
Measures See topic collection
10953
Validity of Retrospective Pretest Methodology
Type: Report
Authors: A. Blount
Year: 2008
Topic(s):
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

10954
Validity of self-reported substance use: research setting versus primary health care setting
Type: Journal Article
Authors: P. Khalili, A. E. Nadimi, H. R. Baradaran, L. Janani, A. Rahimi-Movaghar, Z. Rajabi, A. Rahmani, Z. Hojati, K. Khalagi, S. A. Motevalian
Year: 2021
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
10955
Value and Performance of Accountable Care Organizations: a Cost-Minimization Analysis
Type: Journal Article
Authors: S. Parasrampuria, A. H. Oakes, S. S. Wu, M. A. Parikh, W. V. Padula
Year: 2018
Publication Place: England
Abstract: OBJECTIVES: Determine the relationship between quality of an accountable care organization (ACO) and its long-term reduction in healthcare costs. METHODS: We conducted a cost minimization analysis. Using Centers for Medicare and Medicaid cost and quality data, we calculated weighted composite quality scores for each ACO and organization-level cost savings. We used Markov modeling to compute the probability that an ACO transitioned between different quality levels in successive years. Considering a health-systems perspective with costs discounted at 3 percent, we conducted 10,000 Monte Carlo simulations to project long-term cost savings by quality level over a 10-year period. We compared the change in per-member expenditures of Pioneer (early-adopters) ACOs versus Medicare Shared Savings Program (MSSP) ACOs to assess the impact of coordination of care, the main mechanism for cost savings. RESULTS: Overall, Pioneer ACOs saved USD 641.24 per beneficiary and MSSP ACOs saved USD 535.59 per beneficiary. By quality level: (a) high quality organizations saved the most money (Pioneer: USD 459; MSSP: USD 816); (b) medium quality saved some money (Pioneer: USD 222; MSSP: USD 105); and (c) low quality suffered financial losses (Pioneer: USD -40; MSSP: USD -386). CONCLUSIONS: Within the existing fee-for-service healthcare model, ACOs are a mechanism for decreasing costs by improving quality of care. Higher quality organizations incorporate greater levels of coordination of care, which is associated with greater cost savings. Pioneer ACOs have the highest level of integration of services; hence, they save the most money.
Topic(s):
Financing & Sustainability See topic collection
10956
Value and Performance of Accountable Care Organizations: a Cost-Minimization Analysis
Type: Journal Article
Authors: S. Parasrampuria, A. H. Oakes, S. S. Wu, M. A. Parikh, W. V. Padula
Year: 2018
Publication Place: England
Abstract: OBJECTIVES: Determine the relationship between quality of an accountable care organization (ACO) and its long-term reduction in healthcare costs. METHODS: We conducted a cost minimization analysis. Using Centers for Medicare and Medicaid cost and quality data, we calculated weighted composite quality scores for each ACO and organization-level cost savings. We used Markov modeling to compute the probability that an ACO transitioned between different quality levels in successive years. Considering a health-systems perspective with costs discounted at 3 percent, we conducted 10,000 Monte Carlo simulations to project long-term cost savings by quality level over a 10-year period. We compared the change in per-member expenditures of Pioneer (early-adopters) ACOs versus Medicare Shared Savings Program (MSSP) ACOs to assess the impact of coordination of care, the main mechanism for cost savings. RESULTS: Overall, Pioneer ACOs saved USD 641.24 per beneficiary and MSSP ACOs saved USD 535.59 per beneficiary. By quality level: (a) high quality organizations saved the most money (Pioneer: USD 459; MSSP: USD 816); (b) medium quality saved some money (Pioneer: USD 222; MSSP: USD 105); and (c) low quality suffered financial losses (Pioneer: USD -40; MSSP: USD -386). CONCLUSIONS: Within the existing fee-for-service healthcare model, ACOs are a mechanism for decreasing costs by improving quality of care. Higher quality organizations incorporate greater levels of coordination of care, which is associated with greater cost savings. Pioneer ACOs have the highest level of integration of services; hence, they save the most money.
Topic(s):
Financing & Sustainability See topic collection
10957
Value-Based Care Alone Won't Reduce Health Spending and Improve Patient Outcomes
Type: Report
Authors: David Bailey
Year: 2017
Publication Place: Boston, MA
Topic(s):
Grey Literature See topic collection
,
Financing & Sustainability See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

10958
Value-based financially sustainable behavioral health components in patient-centered medical homes
Type: Journal Article
Authors: R. G. Kathol, F. DeGruy, B. L. Rollman
Year: 2014
Publication Place: United States
Abstract: Because a high percentage of primary care patients have behavioral problems, patient-centered medical homes (PCMHs) that wish to attain true comprehensive whole-person care will find ways to integrate behavioral health services into their structure. Yet in today's health care environment, the incorporation of behavioral services into primary care is exceptional rather than usual practice. In this article, we discuss the components considered necessary to provide sustainable, value-added integrated behavioral health care in the PCMH. These components are to: (1) combine medical and behavioral benefits into one payment pool; (2) target complex patients for priority behavioral health care; (3) use proactive onsite behavioral "teams;" (4) match behavioral professional expertise to the need for treatment escalation inherent in stepped care; (5) define, measure, and systematically pursue desired outcomes; (6) apply evidence-based behavioral treatments; and (7) use cross-disciplinary care managers in assisting the most complicated and vulnerable. By adopting these 7 components, PCHMs will augment their ability to achieve improved health in their patients at lower cost in a setting that enhances ease of access to commonly needed services.
Topic(s):
Financing & Sustainability See topic collection
,
Medical Home See topic collection
10959
Value-Based Payment As Part Of A Broader Strategy To Address Opioid Addiction Crisis
Type: Report
Authors: Joshua Barrett, Mingjie Li, Brigitta Spaeth-Rublee, Harold A. Pincus
Year: 2017
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

10960
Value-based payment in implementing evidence-based care: the Mental Health Integration Program in Washington state
Type: Journal Article
Authors: Y. Bao, T. G. McGuire, Y. F. Chan, A. A. Eggman, A. M. Ryan, M. L. Bruce, H. A. Pincus, E. Hafer, J. Unutzer
Year: 2017
Publication Place: United States
Abstract: OBJECTIVES: To assess the role of value-based payment (VBP) in improving fidelity and patient outcomes in community implementation of an evidence-based mental health intervention, the Collaborative Care Model (CCM). STUDY DESIGN: Retrospective study based on a natural experiment. METHODS: We used the clinical tracking data of 1806 adult patients enrolled in a large implementation of the CCM in community health clinics in Washington state. VBP was initiated in year 2 of the program, creating a natural experiment. We compared implementation fidelity (measured by 3 process-of-care elements of the CCM) between patient-months exposed to VBP and patient-months not exposed to VBP. A series of regressions were estimated to check robustness of findings. We estimated a Cox proportional hazard model to assess the effect of VBP on time to achieving clinically significant improvement in depression (measured based on changes in depression symptom scores over time). RESULTS: Estimated marginal effects of VBP on fidelity ranged from 9% to 30% of the level of fidelity had there been no exposure to VBP (P <.05 for every fidelity measure). Improvement in fidelity in response to VBP was greater among providers with a larger patient panel and among providers with a lower level of fidelity at baseline. Exposure to VBP was associated with an adjusted hazard ratio of 1.45 (95% confidence interval, 1.04-2.03) for achieving clinically significant improvement in depression. CONCLUSIONS: VBP improved fidelity to key elements of the CCM, both directly incentivized and not explicitly incentivized by the VBP, and improved patient depression outcomes.
Topic(s):
Financing & Sustainability See topic collection